Relmada Therapeutics, Inc. (RLMD)
NASDAQ
Market Cap
$90.22M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
148 of 809
Rank in Industry
98 of 445
Largest Insider Buys in Sector
RLMD Stock Price History Chart
RLMD Stock Performance
About Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.
Insider Activity of Relmada Therapeutics, Inc.
Over the last 12 months, insiders at Relmada Therapeutics, Inc. have bought $663,374 and sold $0 worth of Relmada Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Relmada Therapeutics, Inc. have bought $309,719 and sold $1.99M worth of stock each year.
Highest buying activity among insiders over the last 12 months: TRAVERSA SERGIO (Chief Executive Officer) — $773,475. Ence Chuck (CA and CO) — $150,920. Shenouda Maged (Chief Financial Officer) — $125,717.
The last purchase of 27,460 shares for transaction amount of $109,752 was made by TRAVERSA SERGIO (Chief Executive Officer) on 2024‑01‑31.
List of Insider Buy and Sell Transactions, Relmada Therapeutics, Inc.
| 2024-01-31 | TRAVERSA SERGIO | Chief Executive Officer | 27,460 0.0923% | $4.00 | $109,752 | +15.39% | ||
| 2024-01-31 | Ence Chuck | CA and CO | 13,670 0.0466% | $4.05 | $55,429 | +15.39% | ||
| 2024-01-31 | Shenouda Maged | Chief Financial Officer | 6,875 0.0235% | $4.06 | $27,943 | +15.39% | ||
| 2024-01-30 | TRAVERSA SERGIO | Chief Executive Officer | 40,999 0.1345% | $3.90 | $159,949 | +15.05% | ||
| 2024-01-30 | Shenouda Maged | Chief Financial Officer | 15,000 0.0491% | $3.89 | $58,323 | +15.05% | ||
| 2024-01-30 | Ence Chuck | CA and CO | 14,500 0.0471% | $3.87 | $56,053 | +15.05% | ||
| 2024-01-29 | TRAVERSA SERGIO | Chief Executive Officer | 31,541 0.1037% | $3.71 | $117,036 | +19.15% | ||
| 2024-01-29 | Shenouda Maged | Chief Financial Officer | 10,800 0.035% | $3.65 | $39,450 | +19.15% | ||
| 2024-01-29 | Ence Chuck | CA and CO | 10,800 0.0349% | $3.65 | $39,438 | +19.15% | ||
| 2023-05-23 | O'Gorman Cedric | Chief Medical Officer | 10,000 0.0338% | $3.18 | $31,800 | +0.64% | ||
| 2022-12-08 | TRAVERSA SERGIO | Chief Executive Officer | 55,250 0.1801% | $2.10 | $115,804 | +37.79% | ||
| 2022-06-30 | Sale | TRAVERSA SERGIO | Chief Executive Officer | 4,068 0.0131% | $18.32 | $74,526 | -78.46% | |
| 2022-04-04 | Sale | Kelly Paul Edward | 10,000 0.0335% | $30.04 | $300,395 | -39.79% | ||
| 2022-04-01 | Sale | CASAMENTO CHARLES J | 3,300 0.0109% | $29.00 | $95,700 | -37.76% | ||
| 2021-09-22 | Sale | CASAMENTO CHARLES J | director | 6,600 0.038% | $29.00 | $191,400 | -22.24% | |
| 2021-07-15 | Sale | CASAMENTO CHARLES J | director | 3,300 0.0189% | $31.54 | $104,088 | -29.07% | |
| 2021-06-01 | Sale | CASAMENTO CHARLES J | director | 3,000 0.0182% | $33.34 | $100,020 | -26.34% | |
| 2021-05-03 | Sale | CASAMENTO CHARLES J | director | 3,000 0.0176% | $38.22 | $114,647 | -35.43% | |
| 2021-04-01 | Sale | CASAMENTO CHARLES J | director | 3,000 0.017% | $35.43 | $106,281 | -32.36% | |
| 2021-03-10 | Sale | TRAVERSA SERGIO | CEO | 2,983 0.0181% | $35.09 | $104,676 | -27.16% |
Insider Historical Profitability
5.01%
| TRAVERSA SERGIO | Chief Executive Officer | 244024 0.8107% | $2.99 | 6 | 14 | <0.0001% |
| Ence Chuck | CA and CO | 38970 0.1295% | $2.99 | 3 | 0 | |
| Shenouda Maged | Chief Financial Officer | 34903 0.116% | $2.99 | 6 | 14 | <0.0001% |
| Kelly Paul Edward | 187295 0.6223% | $2.99 | 5 | 11 | +87.38% | |
| SETH SANDESH | director | 123258 0.4095% | $2.99 | 2 | 0 | <0.0001% |
| O'Gorman Cedric | Chief Medical Officer | 10121 0.0336% | $2.99 | 1 | 0 | +0.64% |
| CASAMENTO CHARLES J | 9900 0.0329% | $2.99 | 1 | 15 | <0.0001% | |
| Agharkar Shreeram | director | 5759 0.0191% | $2.99 | 2 | 0 | <0.0001% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| The Vanguard Group | $5.84M | 4.17 | 1.26M | -4.13% | -$251,564.99 | <0.0001 | |
| Deep Track Capital Lp | $5.77M | 4.11 | 1.24M | -39.35% | -$3.74M | 0.03 | |
| Acadian Asset Management | $5.49M | 3.92 | 1.18M | -0.14% | -$7,617.86 | 0.02 | |
| Parsons Capital Management Inc Ri | $4.53M | 3.23 | 973,520 | +2.49% | +$110,107.35 | 0.3 | |
| Opaleye Management Inc | $3.53M | 2.52 | 759,000 | -13.46% | -$548,700.00 | 0.56 | |
| Palo Alto Investors Lp | $3.41M | 2.43 | 732,400 | 0% | +$0 | 0.38 | |
| Franklin Templeton Investments | $2.93M | 2.09 | 630,251 | New | +$2.93M | <0.01 | |
| BlackRock | $2.69M | 1.92 | 578,188 | +0.95% | +$25,319.25 | <0.0001 | |
| Millennium Management LLC | $1.59M | 1.13 | 341,450 | +71.67% | +$662,852.64 | <0.01 | |
| Two Sigma Advisers LP | $1.52M | 1.08 | 326,200 | -0.64% | -$9,765.00 | <0.01 | |
| Geode Capital Management | $1.19M | 0.85 | 256,087 | +5.21% | +$58,948.77 | <0.0001 | |
| Two Sigma | $1.06M | 0.75 | 227,039 | -25.01% | -$352,028.13 | <0.01 | |
| Deutsche Bank | $1.05M | 0.75 | 224,846 | 0% | +$0 | <0.0001 | |
| Bank of America | $979,178.00 | 0.7 | 210,576 | -0.03% | -$255.75 | <0.0001 | |
| Marshall Wace | $966,596.00 | 0.69 | 207,870 | +35.4% | +$252,704.38 | <0.01 | |
| Bridgeway Capital Management | $910,363.00 | 0.65 | 195,777 | +15.11% | +$119,504.99 | 0.02 | |
| Guild Investment Management | $888,150.00 | 0.63 | 191,000 | -9.95% | -$98,115.00 | 1.2 | |
| Group One Trading | $857,172.00 | 0.61 | 184,338 | +16.36% | +$120,486.19 | 0.03 | |
| JPMorgan Chase | $818,298.00 | 0.58 | 175,978 | +836.25% | +$730,896.57 | <0.0001 | |
| Jane Street Capital | $814,815.00 | 0.58 | 175,229 | +1,344% | +$758,387.24 | <0.01 | |
| RBF Capital, LLC | $769,454.00 | 0.55 | 165,474 | 0% | +$0 | 0.04 | |
| Barclays | $679,000.00 | 0.48 | 145,999 | 0% | +$0 | <0.0001 | |
| UBS | $601,175.00 | 0.43 | 129,285 | +2.83% | +$16,530.74 | <0.0001 | |
| Jacobs Levy Equity Management | $585,509.00 | 0.42 | 125,916 | -41.06% | -$407,823.32 | <0.01 | |
| Citigroup | $575,730.00 | 0.41 | 123,813 | +69.32% | +$235,708.32 | <0.0001 | |
| Morgan Stanley | $560,391.00 | 0.4 | 120,514 | +33.74% | +$141,378.83 | <0.0001 | |
| Goldman Sachs | $549,830.00 | 0.39 | 118,243 | New | +$549,830.00 | <0.0001 | |
| State Street | $516,750.00 | 0.37 | 111,129 | -3.56% | -$19,065.01 | <0.0001 | |
| Gsa Capital Partners Llp | $480,000.00 | 0.34 | 103,321 | -44.02% | -$377,473.70 | 0.04 | |
| One Seven (We Are One Seven, LLC) | $465,000.00 | 0.33 | 100,000 | 0% | +$0 | 0.03 | |
| Silverarc Capital Management Llc | $462,112.00 | 0.33 | 99,379 | -0.62% | -$2,887.65 | 0.14 | |
| Federated Hermes | $446,447.00 | 0.32 | 96,010 | -3.83% | -$17,804.87 | <0.01 | |
| Fidelity Investments | $389,889.00 | 0.28 | 83,847 | -0.36% | -$1,399.65 | <0.0001 | |
| Northern Trust | $376,877.00 | 0.27 | 81,049 | -15.81% | -$70,763.54 | <0.0001 | |
| Squarepoint Ops LLC | $367,410.00 | 0.26 | 79,013 | +7.6% | +$25,942.32 | <0.01 | |
| Apricus Wealth Llc | $366,708.00 | 0.26 | 78,862 | 0% | +$0 | 0.26 | |
| Dimensional Fund Advisors | $343,263.00 | 0.25 | 73,820 | 0% | +$0 | <0.0001 | |
| Cantor Fitzgerald L P | $357,210.00 | 0.24 | 73,500 | New | +$357,210.00 | 0.01 | |
| Qube Research & Technologies | $339,352.00 | 0.24 | 72,979 | +1,367.21% | +$316,222.92 | <0.0001 | |
| Man Group Plc | $336,279.00 | 0.24 | 72,318 | New | +$336,279.00 | <0.01 | |
| Citadel Advisors LLC | $328,030.00 | 0.23 | 70,544 | -81.22% | -$1.42M | <0.0001 | |
| AdvisorShares | $325,746.00 | 0.23 | 70,053 | -6.18% | -$21,450.42 | 0.03 | |
| Cubist Systematic Strategies | $237,899.00 | 0.17 | 51,161 | New | +$237,899.00 | <0.01 | |
| Point72 Asia Singapore Pte Ltd | $231,951.00 | 0.17 | 49,882 | New | +$231,951.00 | 0.02 | |
| Simplex Trading Llc | $217,000.00 | 0.16 | 46,713 | -16.56% | -$43,072.04 | 0.01 | |
| Jump Financial Llc | $210,408.00 | 0.15 | 45,249 | New | +$210,408.00 | <0.01 | |
| Ikarian Capital LLC | $187,717.00 | 0.13 | 40,369 | 0% | +$0 | 0.05 | |
| SEI Investments Company | $168,890.00 | 0.12 | 36,320 | 0% | +$0 | <0.0001 | |
| Renaissance Technologies | $163,000.00 | 0.12 | 35,008 | -76.17% | -$520,926.73 | <0.0001 | |
| Meyer Handelman Co | $151,334.00 | 0.11 | 32,545 | 0% | +$0 | 0.01 |